Sort   by:  
 Page size 
UnknownVascular Endothelial Growth Factor-B Blockade with CSL346 in Diabetic Kidney Disease: A Phase 2A Randomized Controlled Trial.
Not available
S-EPMC11543004 | biostudies-literature
UnknownInhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy.
Not available
S-EPMC6093931 | biostudies-literature
UnknownSeverity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.
Not available
S-EPMC4309077 | biostudies-literature
UnknownChronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults.
Not available
S-EPMC4818564 | biostudies-literature
UnknownFactors associated with D-dimer levels in HIV-infected individuals.
Not available
S-EPMC3953205 | biostudies-literature
UnknownAssociation of BMI and Cognitive Performance in the Diabetes Prevention Program Outcomes Study.
Not available
S-EPMC12636062 | biostudies-literature
UnknownChange in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD.
Not available
S-EPMC10278784 | biostudies-literature
UnknownEffect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes.
Not available
S-EPMC5706112 | biostudies-literature
UnknownPharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.
Not available
S-EPMC8102467 | biostudies-literature
UnknownAge-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis.
Not available
S-EPMC8473559 | biostudies-literature
Sort   by:  
 Page size